December 2012
Our division's director Marc E. Rothenberg, MD, PhD, and fellowship program director Kimberly A. Risma, MD, PhD, were named among Cincy Magazine's list of Best Doctors for 2013.
November 12, 2012
Leading Food Allergy Organizations Announce Completion of Merger and Introduce New Name
Read about the merger of the Food Allergy Initiative (FAI) and Food Allergy & Anaphylaxis Network (FAAN) into FARE (Food Allergy Research & Education).
November 5, 2012
Frank Sasinowski, Vice Chair of the Board of Directors for NORD, mentions his work and Keynote Speech at the CURED EGID Research Symposium in the FDA Law Blog.
November 2-4, 2012
CURED (Campaign Urging Research for Eosinophilic Disease) EGID (Eosinophilic Gastrointestinal Disorder) Research Symposium
November 3, 2012
Children's director is Red Cross hero
Read more about the work of our division's business director, Kevin Titus, as he answer questions about his important work as a Red Cross public affairs manager.
November 1, 2012
CURED Foundation Makes Generous Donation of $150,000 to the Cincinnati Center for Eosinophilic Disorders Research Efforts. This brings the total amount of money donated to the Center by CURED to $2,114,000 in the past 10 years.
October 23, 2012
Santa Jeremy Ono Named President of the University of Cincinnati
The Board of Trustees of the University of Cincinnati voted unanimously to appoint Santa Ono, PhD, as President of the University of Cincinnati. Ono had been appointed Interim President at the University of Cincinnati in August 2012, following the resignation of Gregory H. Williams. Ono first arrived at the University of Cincinnati in 2010, serving two years as the Senior Vice President for Academic Affairs and Provost. As provost, he led the development of an academic master plan aligned to the university’s strategic plan, “UC2019: Accelerating Our Transformation.” The academic master plan, unveiled in May 2012, included an initial investment of about $10 million toward long-term strategic goals set for completion in the University of Cincinnati's bicentennial year of 2019. President Ono is one of a handful of university presidents in the nation who have fully embraced social media and has more than 6,700 followers of his Twitter feed: @PrezOno.
October 2012
At Cincinnati Children's Recognition Dinner, honoring employees with 10- to 50-year service anniversaries, Amal H. Assa'ad, MD, and Thomas J. Fischer, MD, from our division were honored for their 20 years and 35 years, respectively, of dedicated service at Cincinnati Children's.
October 3, 2012
Springdale boy shows super strength, spirit
Read about Jordan Scott and the Eosinophilic Avengers who walked on Saturday, October 20, 2012 at Cincinnati Walks for Kids.
August 2012
Amal H. Assa'ad, MD, having led the Allergy/Immunology Fellowship Program as Fellowship Director for 17 years with dedication and excellence, has passed this role onto Kimberly A. Risma, MD, PhD. We look forward to Amal H. Assa'ad's continued involvement in teaching our future allergists in this combined pediatric and adult fellowship program (via partnership with the University of Cincinnati) as this program is an integral part of our division's mission to improve the health of children with allergic and immune conditions through innovative research, outstanding clinical care, and education of the current and next generation of leaders in healthcare and research.
July 25, 2012
CCED and CEFC Annual Interactive Eosinophilic Research Lab Day
Marc Rothenberg, MD, PhD, and other pediatrics researchers in his lab and the Cincinnati Center for Eosinophilic Disorders (CCED) hosted their annual interactive eosinophilic research interactive lab day in collaboration with the Cincinnati Eosinophilic Family Coalition (CEFC).
June 6, 2012
Clinical Director elected to the AAAAI Board of Directors
Our division's clinical director, Amal H. Assa'ad, MD, was elected to the American Academy of Asthma, Allergy and Immunology (AAAAI)'s Board of Directors.
May 20, 2012
CURED Foundation Makes Generous Donation
Ellyn, Jori and Fred Kodroff and the CURED Foundation once again showed their generosity by donating $150,000 to our research efforts in the Cincinnati Center for Eosinophilic Disorders (CCED) and on eosinophilic disorders. Their commitment, drive and determination to find a cure has made a significant difference in advancing research and our understanding of eosinophilic disorders and will help to change the outcome for families around the world.
May 13-19, 2012
National Eosinophilic Awareness Week and Food Allergy Awareness Week
Members of the Division of Allergy and Immunology were involved in several activities for this week to increase awareness of both eosinophilic disorders and food allergies, including the second annual Camp CouragEOS hosted by the Cincinnati Center for Eosinophilic Disorders. Our main cafeteria also started to sell allergy-free foods.
May 10, 2012
For Teen With Eosinophils of the Esophagus, Food Is Forbidden
In this news article, Marc Rothenberg, MD, PhD, comments on how dietary restrictions can be disabling and that people with eosinophilic disorders have been shown to have the lowest quality of life as compared to a variety of other pediatric chronic diseases.
May 9, 2012
Merger of the Food Allergy Initiative (FAI) and the Food Allergy & Anaphylaxis Network (FAAN) Announced
May 2, 2012
Researchers Evaluate Dietary Regimens of Allergic Disease
Marc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have taken a critical step in improving patient care by evaluating the comparative effectiveness of current dietary therapies (elemental diet, six-food elimination diet, skin test-directed elimination diet) and the utility of skin test-directed diets in food reintroductions for eosinophilic esophagitis. The study found that while all three of the evaluated dietary therapies are effective in decreasing activity of the disease, the elemental diet is superior and using skin testing to direct diets was not helpful compared with empiric removal of certain ‘high risk’ foods.
May 1, 2012
Israel's Top 10 Advances in Asthma
In this news article, Ariel Munitz, PhD, is mentioned for his recent research collaborative efforts in designing a small antibody fragment that may be able to target the cause of asthma and allergies by targeting a receptor protein on the surface of mast cells.
March 31, 2012
How Do You Tell the Difference Between Seasonal Allergies and a Cold?
In this news article, Michelle B. Lierl, MD, comments on how to distinguish between allergies and the common cold, which is important for getting proper treatment.
March 28, 2012
Researchers Identify New Regulator in Allergic Diseases
Marc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have taken a critical step in understanding how allergic reactions occur after identifying a genetic signature for regulation of a key immune hormone, interleukin 13 (IL-13). The study identifies that microRNA 375 is regulated by IL-13, and in turn regulates how IL-13 induces pro-allergic changes, particularly in epithelial cells in the lung and esophagus. The data support a role for microRNA 375 in asthma and eosinophilic esophagitis.
March 26, 2012
Passing of Our Friend and Mentor Dr. Leonard I. Bernstein
Our friend, mentor, and beloved colleague. Dr. Leonard Bernstein, a pioneer in the Allergy / Immunology field and founder of Allergy / Immunology in Cincinnati passed away at age 88, on March 26, 2012. Dr. Bersnstein was the beloved husband of Miriam G. Bernstein, devoted father of Dr. David (Cheryl) Bernstein, Dr. Susan (Howard Ain) Bernstein, Dr. Jonathan (Lisa) Bernstein & the late Ellen B. Ganson (Michael Ganson), dear brother of the late Leah Geber, loving grandfather of Daniel (Jaime Aronson) & William Bernstein, Aaron, Joel (Alyce Baier), Rachel & Marisa Ellison, Jason & Andrew (Emily Sanchez) Ain, Adam, Sarah & Philip Ganson & Alison, Joshua, Rebecca & Caren Bernstein.
With the passing of Dr. I. Leonard Bernstein, his family, the University of Cincinnati, the city of Cincinnati and the field of Allergy and Immunology have lost a great father, friend and a mentor.
Memorial contributions can be made to the Ellen B. Ganson Fund c/o Rockwern Academy, 8401 Montgomery Rd., Cinti, OH 45236 or the Bernstein Endowment Fund for Allergy Research & Education at the U.C. Foundation, P.O. Box 670544, Cinti, OH 45321.
March 9, 2012
Genetic Marker for Painful Food Allergy Points to Improved Diagnosis, Treatment
Marc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have identified a genetic signature for a severe, often painful food allergy – eosinophilic esophagitis – that could lead to improved diagnosis and treatment for children unable to eat a wide variety of foods. The researchers found that EoE was associated with 32 differentially regulated microRNAs and distinguishable from the non-eosinophilic forms of esophagitis (such as reflux disease). Esophageal eosinophil levels correlated significantly with expression of the most increased microRNAs, miR-21 and miR-223, and most decreased, miR-375. MiR-223 was also one of the most increased microRNAs in the plasma, along with miR-146a and miR-146b. Notably, the expression of microRNAs dysregulated in patients with active EoE was normalized in patients with EoE who responded to steroid treatment. This suggests a significantly specific microRNA signature for disease activity points to its promise for use as a biomarker for EoE.
January 6, 2012
Asthma Worse for Children in Single-Parent Homes
Terri Moncrief, MD, faculty member of the Division of Allergy and Immunology at Cincinnati Children’s, was the lead author of this study, which found that children from single-parent homes admitted to the hospital for asthma or wheezing are 50 percent more likely to return to the hospital within a year than children from two-parent homes.